Pneumococcal Immunization Resources for Healthcare Providers

Pneumococcal

Clinical Resources

Materials for Providers

Alphabetical by Title

Recommendations for Pneumococcal Vaccines Use in Children and Teens

This piece gives recommendations for pneumococcal vaccines use in children and teens who are healthy or have risk factors.

View PDF

Standing Orders for Administering Pneumococcal Vaccines to Adults

Eligible healthcare professionals may vaccinate adults who meet any of the criteria on this form

View PDF

Standing Orders for Administering Pneumococcal Vaccines to Children and Teens

Eligible healthcare professionals may vaccinate children or adolescents who meet any of the criteria on this form

View PDF

Materials for Vaccine Recipients

Alphabetical by Title

Pneumococcus: Questions and Answers

Information about the disease and vaccines for patients and parents

View PDF

View all Clinical Resources

Ask the Experts

What is pneumococcal serotype 4 and when might it be considered when selecting a pneumococcal vaccine product for adults?

Where would I find information about pneumococcal serotype 4 prevalence for my community?

What vaccines are indicated for someone who does not have a functioning spleen?

My 36-year-old patient was diagnosed with idiopathic thrombocytopenic purpura and had a splenectomy three weeks ago. Prior to the splenectomy, he had one dose each of Hib, MenB, PCV20, and MenACWY (Menveo). What vaccines are recommended now?

ACIP Recommendations

Current Recommendations

Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines among Adults aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

MMWR January 9, 2025;74:1–8

Read at CDC.gov

View PDF

Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

MMWR September 12, 2024 / 73(36);793–798

Read at CDC.gov

View PDF

ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023

MMWR. September 29, 2023 / 72(39);1072

Read at CDC.gov

View PDF

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.

MMWR. September 8, 2023 / 72(RR-3);1–39

Read at CDC.gov

View PDF

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022

MMWR, September 16, 2022, 71(37);1174–1181

Read at CDC.gov

View PDF

Additional Federal Resources

Vaccine Information Statements

Multi-Vaccine VIS

Updated: July 24, 2023

View PDF

PCV (Pneumococcal Conjugate) VIS

Updated: May 12, 2023

View PDF

PPSV (Pneumococcal Polysaccharide) VIS

Updated: October 30, 2019

View PDF

CDC Recommended Schedules

2025 Child and Adolescent Immunization Schedule

Page count: 17
Color
Size: 8.5 ” x 11″

View PDF

2025 Adult Immunization Schedule

Page count: 15
Color
Size: 8.5 ” x 11″

View PDF

FDA Package Inserts & EUAs

Pneumococcal (PCV): Capvaxive Package Insert

Merck & Co., Inc.

View PDF

Capvaxive Product Approval

Pneumococcal (PCV): Prevnar 20 Package Insert

Pfizer

View PDF

Prevnar 20 Product Approval

Pneumococcal (PCV): Vaxneuvance (PCV15) Package Insert

Merck & Co, Inc.

View PDF

Vaxneuvance (PCV15) Product Approval

Pneumococcal (PCV): Prevnar 13 Package Insert

Pfizer

View PDF

Prevnar 13 Product Approval

Pneumococcal (PPSV): Pneumovax 23 Package Insert

Merck & Co., Inc.

View PDF

Pneumovax 23 Product Approval

State Policies

View Pneumococcal Conjugate Vaccine (PCV) Requirements for Childcare

U.S. map of PCV requirements

View PDF

Travel

All travelers should be up to date on routine vaccines. Depending on the destination, itinerary, and duration of travel, additional vaccines may be recommended.